Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis.
Mahmoud NassarHazem Maarouf AbosheaishaaAwadhesh Kumar SinghAnoop MisraZachary BloomgardenPublished in: Journal of diabetes (2023)
AGM use was not associated with increased mortality. However, metformin and GLP-1RA use reduced mortality risk statistically significantly. DPP-4i use was associated with a statistically significant increase in the risk of hospitalization and admission to the ICU.
Keyphrases
- coronavirus disease
- sars cov
- intensive care unit
- rheumatoid arthritis
- emergency department
- cardiovascular events
- mechanical ventilation
- risk factors
- disease activity
- ankylosing spondylitis
- cardiovascular disease
- coronary artery disease
- type diabetes
- interstitial lung disease
- systemic sclerosis
- systemic lupus erythematosus
- acute respiratory distress syndrome
- idiopathic pulmonary fibrosis
- extracorporeal membrane oxygenation